3 ms·
Here is Derek’s blog post and reference to the original paper. They were quite explicit on what counts as “discovering” a new drug. It’s whoever first created
by refurb 8y ago
Here is Derek’s blog post and reference to the original paper. They were quite explicit on what counts as “discovering” a new drug. It’s whoever first created the drug and identified it as having potential to treat a disease.[1]
[1]http://blogs.sciencemag.org/pipeline/archives/2010/11/04/where_drugs_come_from_the_numbers http://blogs.sciencemag.org/pipeline/archives/2010/11/04/whe...
- aaavl2821 8y agoThanks, I actually hadn't seen that. The data I was referring to is from my own analysis of 2017 new drug approvals on FDA's website That paper covers 1998 to 2010, roughly coinciding with the end of the booming era of cardiovascular and psychiatric small molecules (prozac, lipitor etc) and ending right before the patent cliff in 2012, which saw the pharma industry's revenue shrink for the first time ever Since then, R&D has shifted strongly to smaller companies from big ones, as the data reflects.